Arclio showed the receipts of clinical study reports, demonstrating the evidence chain behind every value in a clinical study report, one click from source.
Published
Signal category
Products & Services
Quote
“We've shown surveys become data, data become tables, protocol become draft report. This time, Arclio shows the receipts: the evidence chain behind every value in a CSR, one click from source, nothing changed quietly.”
— Jacques Kotze|Arclio team
Company
Arclio
FDA-defensible answers from your trial data
- Industry
- Technology, Information and Internet
- Location
- New York, US
- Company size
- 3 employees
Arclio is a clinical-evidence platform for biopharma. It gives regulatory, clinical, and biostatistics teams FDA-defensible answers from their trial data in 30 seconds, not three days. Unlike tools that only show where a number came from, Arclio proves it correct and unaltered through deterministic, re-runnable computations on a tamper-evident evidence chain. The agent runs entirely inside your own infrastructure — no data ever moves. It produces publication-grade charts and an FDA readiness scorecard across efficacy, safety, data quality, competitive positioning, and biomarkers.
Founded 2025